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1. Introduction 
Bronchoscopic balloon dilation (BBD) is a useful method of treating tracheobronchial 
stenosis. Tracheobronchial stenosis in adults can arise from benign or malignant disease. 
Benign stenosis causes include sarcoidosis, tuberculosis, Wegener’s granulomatosis, trauma, 
berylliosis, and foreign body reaction. Furthermore, it can arise after prolonged 
endotracheal intubation, after sleeve resection or after lung transplantation. Despite 
adequate systemic therapy, airway stenosis may progress due to tuberculosis or sarcoidosis. 
In infants, prior use of endobronchial and tracheostomy tubes or congenital stenosis from 
complete cartilaginous rings are the primary reasons for such stenosis (McDonald & Stocks, 
1965; Parkin ea al., 1976). Subglottic or tracheal sites are thus common and may continue to 
present serious and often fatal respiratory problems in infants. In adults, the etiologies are 
variable and the stricture can happen in any part of the airway. Tracheobronchial stenosis 
may produce symptoms such as dyspnea, cough, wheeze, stridor, or recurrent lower 
respiratory tract infections, and these symptoms cause the airway stricture to mimic asthma. 
There are various treatments including surgical resection, laser resection, and bougie 
dilation during rigid bronchoscopy. For lesions causing impending respiratory failure, 
surgical resection or stent placement is the most prudent treatment. In less urgent 
conditions, BBD has been considered a simple, rapid, and safe method to restore airway 
caliber. BBD has been used alone or in combination with other modalities such as laser 
resection, cryotherapy, and electrocautery. In 1984, Cohen et al. (Cohen et al., 1984) reported 
a successful balloon dilation through a tracheostomy tube under propylidone injection for a 
stricture after segmental resection of congenital stenosis in an infant. In 1987, Fowler et al. 
(Fowler et al., 1987) described bronchoscopic balloon dilation using a rigid bronchoscope for 
anastomotic stenosis in an adult who had had a sleeve resection for an endobronchial 
squamous cell carcinoma of the right main-stem bronchus 2 years earlier. The following year 
Carlin et al. (Carlin et al., 1988) reported two cases of bronchial stenosis successfully treated 
with a combination of bronchoscopic balloon dilation and Nd-YAG laser photoresection 
with a rigid bronchoscope. In 1991, balloon dilation using flexible bronchoscopy was 
described for the first time by Nakamura et al. (Nakamura et al., 1991). They treated two 
patients with tuberculous bronchial stenosis through a flexible bronchoscope under local 
anesthesia. Since then, several reports of BBD have been published (Ball et al., 1991; Keller & 
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Frost, 1992; Carre et al., 1994; Fouty et al., 1994; Ferretti et al., 1995; Sheski & Mathur, 1998). 
The major advantages of BBD are lower morbidity and mortality than surgery, stent 
placement, or bougienage. BBD has thus become an accepted treatment for benign 
tracheobronchial stenosis. 
2. Indications and contraindications 
Balloon dilation has an indication in almost all benign tracheobronchial strictures. The 
bronchial stenosis caused by tuberculosis finally heals with fibrous scarring through a 
submucosal infiltration by tubercles and lymphocytes, followed by ulceration and growth of 
granulation tissue (Bugher et al., 1937; Wilson, 1945; Auerbach, 1949; Judd, 1947). Stenosis 
from other medical causes such as Wegener’s granulomatosis, sarcoidosis (Fouty et al., 1994; 
Olsson et al., 1979), berylliosis, post-tracheostomy, and complicated tracheobronchial 
anastomosis may also ultimately result in fibrous scars. Such fibrotic stenosis is a good 
indication for BBD. Visual characteristics such as pale or nonedematous mucosa may 
suggest a lesion with little inflammation and a greater likelihood of successful opening 
(Ferretti et al., 1995; Brown et al., 1987). In particular, inoperable long segmental stenosis is 
well treated by BBD. On the other hand, if the bronchial cartilage is destroyed, the success 
rate of BBD is low (Carre et al., 1994). An airway stricture with tracheobronchomalacia 
usually requires combination therapy with another therapeutic modality such as stent 
placement to maintain airway patency. Iwamoto et al. (Iwamoto et al., 2004) reported that 
endobronchial ultrasonography (EBUS) imaging was useful in making a diagnosis of 
cartilaginous tracheobronchomalacia and in aiding the decision as to whether or not a stent 
was needed. In lung transplantation, this endobronchial stenosis may be a result of airway 
rejection or due to ischemic changes at the site of the bronchial implantation. When there 
must be an ongoing process such as airway rejection or ischemia, even if repeated BBD is 
performed, endobronchial stenosis is often recurrent. In malignancy, balloon dilation is 
performed in combination with other modalities such as laser resection, stent placement, 
cryotherapy, and electrocautery (Hautmann et al., 2001). Assessment of the patient’s 
coagulation status before the procedure is important because bleeding is a frequent 
complication of BBD. The decision to continue or withhold anticoagulant or antiplatelet 
drugs should reflect a balance of the consequences of periprocedural hemorrhage versus the 
risk of periprocedural vascular complications. Aspirin, NSAIDs, ibuprofen, clopidigrel, and 
warfarin should be discontinued at least 7-10 days, 3 days, 24 hours, 7-10 days, and 3-5 days 
before BBD, respectively (Douketis et al., 2008; Kearon et al., 1997; Larson et al., 2005). 
Nonacetylated NSAIDs can be continued in the periprocedual period. If the patient cannot 
stop taking any anticoagulant or antiplatelet medication, BBD should be performed 
prudently.  
3. Technique 
BBD is generally performed under topical anesthesia and conscious sedation, but BBD for 
tracheal stenosis will be performed better under general anesthesia with laryngeal mask 
ventilation or tracheal intubation, because long-term respiratory arrest is needed during 
inflation and this would cause great anxiety to the patient. Patients are maintained with 
100% oxygen during the procedure and are hyperventilated immediately before balloon 
inflation. 
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After local or general anesthesia, bronchoscopy is first performed with a diagnostic 
bronchoscope (BF-260; Olympus, Tokyo) or a therapeutic bronchoscope (BF-1T60; Olympus, 
Tokyo) to assess and localize the airway stenosis before balloon dilation. Bronchoscopy 
provides information about not only the localization and extent of the stenosis but also the 
condition of the mucosa and influence of extra-bronchial lesions. Radiopaque markers are 
placed on the surface of the skin to identify the proximal and distal limits of the stenosis. A 
flexible, 0.035-inch guidewire (JagwireTM Plus; Boston Scientific/Medi-tech, Natick, MA) is 
then inserted through the working channel of the bronchoscope and is passed through the 
stenosis (Fig. 1a). This is performed under fluoroscopy to ensure that the guidewire does not 
extend to the pleura. With the guidewire held in place, the bronchoscope is withdrawn. The 
placement of the guidewire should be confirmed with fluoroscopy after the bronchoscope 
has been removed. Next, a balloon catheter (CRETM Fixed Wire & Wire Guided Balloon 
Dilators, HurricaneTM RX Biliary Balloon Dilation Catheter, Max ForceTM TTS; Boston 
Scientific/Medi-tech, Natick, MA) is selected, based on balloon length and diameter in 
relation to the stenosis dimensions. These balloon catheters are made of polyamide and have 
radiopaque markers at the proximal and distal ends of the balloon. They are available in 
variety of size ranges. The balloon is constructed of such material that the nominal diameter 
of the balloon is proportional to the inflation pressure (3-12 atm). The balloon is inflated 
based on that particular balloon catheter’s characteristics. The diameter of the balloon is 
chosen to be the same diameter as that of the lumen measured at the proximal region of the 
normal airway. The length of the balloon is at least 0.5cm greater than that of stenotic 
segment, since the entire stenosis will be dilated when the balloon is inflated. If the inflated 
balloon length is insufficient, the balloon can slip out of the stenosis. If the balloon length is 
too great, there is a potential for airway damage. This diameter and length of the balloon are 
measured by both bronchoscope and chest CT scans. The required width can be estimated 
from a comparison of the bronchoscope diameter to that of the stenosis. The required length 
of balloon is estimated by passing the bronchoscope through the stenosis and by measuring 
the distance between the proximal and distal limits of the obstruction. Three-dimensional 
CT is a useful noninvasive evaluation for BBD (Rooney et al., 2005). It allows for 
preoperative determination of balloon size and length, even if the bronchoscope cannot be 
passed through the obstruction. It can allow an accurate determination of the degree and 
length of stenosis, an evaluation of the airway distal to the stenosis and show the presence 
of multiple stenoses as well as the relationships with mediastinal structures. Furthermore, it 
is a useful noninvasive technique for postoperative follow-up. It can not only evaluate the 
effect of BBD, but also detect complications related to BBD such as a deep laceration, 
pneumomediastinum or mediastinal bleeding (Y. H. Kim et al., 2006). When the stenosis is 
too narrow for a balloon catheter, a smaller balloon catheter is used first to create a passage 
for the larger balloon catheter and a wider and longer balloon may be used by exchanging 
the balloon catheter for another over the guidewire. Under fluoroscopic guidance, an 
appropriately sized balloon catheter is then advanced over the guidewire and positioned 
such that the balloon markers are properly located with respect to the stenosis (Fig. 1b). The 
bronchoscope is again inserted to visualize the stenosis and the balloon catheter (Fig. 1c). 
The balloon is then inflated with a dilute nonionic contrast medium (Iopamidol; Bracco, 
Milan), and the results are observed via both fluoroscopy and bronchoscopy (Fig. 1d). The 
inflation time is between approximately 30 seconds and 2 minutes, depending on the clinical 
tolerance and consequences on cutaneous oxygen saturation. Occasionally the initial 
inflation times must be very short, but they can be increased as dilation proceeds. Nonionic  
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       (a)     (b) 
     
      (c)       (d) 
Fig. 1. a) A guidewire is passed beyond the stenosis, using bronchoscopy and fluoroscopy to 
ensure that the guidewire does not extend to the pleura and then the bronchoscope is 
withdrawn, leaving the guidewire in place. b) The balloon catheter is advanced over a 
guidewire and positioned under fluoroscopy. c) Proper positioning of the proximal end of 
the balloon is confirmed with visualization through the bronchoscope. d) Bronchoscopy 
allows direct monitoring of balloon inflation and deflation with fluoroscopy. 
contrast media are safe for the bronchus because bronchography using nonionic contrast 
media instead of propylidone is performed safely (Morcos et al., 1989, 1990; Riebel & 
Wartner, 1990).  
If the diameter of the deflated catheter is less than that of the working channel, a 
bronchoscope is not needed to remove before the balloon catheter is inserted. A balloon 
catheter is passed over the guidewire through the working channel and positioned within 
the narrowed segment of the airway under bronchoscopic visualization (Fig. 2a, Fig. 2b).  
During inflation, a balloon inflation device with pressure-gauge monitor (AllianceTM 
Inflation Device; Boston Scientific/Medi-tech, Natick, MA) is used to inflate the balloon and 
to monitor the inflation pressure. Success is defined as loss of the typical waist made in the 
wall of the balloon by the stenosis as observed by fluoroscopy and a stable increase in 
tracheobronchial diameter of the stenotic segment by bronchoscopy. If necessary, the 
balloon catheter then can be repositioned or replaced by a larger sized balloon catheter, and 
the procedure repeated until the desired effect is obtained. Adjunctive treatments such as 
laser vaporization or stent placement may precede or follow balloon dilation. Patient who  
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         (a)    (b) 
Fig. 2. a) If the diameter of the deflated catheter is less than that of the working channel, the 
bronchoscope need not be removed before the balloon catheter is inserted. A balloon 
catheter is passed over the guidewire through the working channel and positioned within 
the narrowed segment of the airway under bronchoscopic visualization. b) The balloon is 
inflated and deflated, and the results are observed via both bronchoscopy and fluoroscopy. 
underwent BBD usually discharges the next day of the procedure. If a complication such as 
laceration occurs, the patient needs to be hospitalized for several days to monitor his 
conditions. Follow-up bronchoscopy is performed about 2-4 weeks after dilation. If the 
desired airway diameter is not attained or recurrent stenosis is observed, the balloon 
dilation is repeated until the desired effect is obtained.  
4. Complications 
During BBD, chest pain, bronchospasm and atelectasis have been reported (Brown et al., 
1987; Elkerbout et al., 1993; Hebra et al., 1991). Excessive balloon inflation may lacerate or 
rupture the airway, causing bleeding, pneumothorax, pneumomediastinum, or 
mediastinitis. As far as we know, there are few reports describing lacerations of the 
tracheobronchial tree after balloon dilation. One case of rupture requiring surgical 
management has been reported (Knott et al., 2004). However, other lacerations except for 
this one healed spontaneously and there were no clinical problems (Y. H. Kim et al., 2006; J. 
H. Kim et al., 2007; K. H. Lee et al., 2002). No patients have died during or from problems 
related to BBD. 
5. Results 
Several reports of BBD in adults are available. Technical success is defined by successful 
passing of a balloon catheter through a stenosis. Short-term clinical success is defined as the 
loss of the typical waist made in the wall of the balloon by the stenosis by fluoroscopy, an 
increase in tracheobronchial diameter of the stenotic segment immediately after 
bronchoscopy, and improvement of the patient’s clinical symptoms. Long-term success is 
based on the patient remaining asymptomatic. Recurrence is defined as the return of 
symptoms. Some patients have undergone radiographic evaluation with chest 
roentgenography or CT scan, pulmonary function testing, or bronchoscopy as part of 
follow-up care. The short-term results of balloon dilation to treat benign tracheobronchial 
stenosis have been favorable. Clinical success rates of 63% to 100% have been reported 
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(Carre et al., 1994; Ferretti et al., 1995; Sheski & Mathur, 1998; J. H. Kim et al., 2007; K. W. Lee 
et al., 1999; Mayse et al., 2004). However, the long-term efficacy of balloon dilation in a large 
group of patients has rarely been reported. According to the reports, recurrence rates range 
from 30% to 80% (Carre et al., 1994; Ferretti et al., 1995; Iwamoto et al., 2004; J. H. Kim et al., 
2007; K. H. Lee et al., 2002; K. W. Lee et al., 1999).  
Kim et al. (J. H. Kim et al., 2007) reported that a group of patients with tracheobronchial 
lacerations (n=64) showed better cumulative airway patency than a group without 
tracheobronchial lacerations (n=60) (medium patency duration, 24 vs. 4 months, 
respectively). They concluded that better clinical outcomes might occur following superficial 
or deep lacerations after BBD in patients with a benign tracheobronchial stricture. Lee et al. 
(K. H. Lee et al., 2002) reported that initial symptomatic improvement after BBD was 
achieved in 83% (49/59) of patients, however, during a mean of 32 months follow-up the 
recurrence rate of BBD was high (80%, 39/49). They also reported that the secondary 
patency rate with repeat balloon dilation at 32 months was 43%, a relatively acceptable long-
term result. Lee et al. (K. W. Lee et al., 1999) reported that improvements in dyspnea after 
BBD for tuberculous bronchial stenosis occurred immediately in 73% (11/15), 73% after 1 
month, 73% after 6 months, 64% after 1 year, 64% after 3 years, and 42% after 6 years. They 
concluded that the long-term results of BBD were acceptable. 
We performed BBD in eleven sessions for benign tracheobronchial stenoses in 8 patients 
between December 1987 and March 2009. The patients were four males and four females, 
and ranged in age from 30 to 60 years. The indications were tuberculous stenosis (n=6), 
post-tracheostomy stricture (n=1) and post-bronchoplasty anastmous stenosis (n=1). The 
sites of stenosis were the trachea (n=4), left main bronchus (n=3), right main bronchus (n=2), 
left upper bronchus (n=1), and left lower bronchus (n=1). Stenoses ranged in diameter from 
pinhole (more than 90%) to 70%, and in length from 0.5 to 6 cm. They were followed up for 
3-48 months (mean follow-up 26.7 months) with radiographic evaluation by chest 
roentgenography or CT scan, pulmonary function testing, or bronchoscopy after BBD. BBD 
was performed under local anesthesia in 3 patients and general anesthesia in 5 patients. For 
tracheal stenosis, 8-18 mm diameter balloons (55-80 mm long) were used. For bronchial 
stenosis, 4-12 mm diameter balloons (20-55 mm long) were used. The results in seven of 
eight treated patients were successful in maintaining airway patency. The only one 
unsuccessful patient was one of post-tracheostomy stenosis resulting in secondary 
tracheomalacia, and this patient needed T-tube stent placement to support the weakened 
cartilage and prevent dynamic airway collapse. As regards complications, there were four 
patients with longitudinal tracheal or bronchial lacerations, but all lacerations healed 
spontaneously after conservative treatment. Thus, a laceration should be regarded as an 
expected result of sufficient balloon dilation, not as a major complication. There were no 
recurrences during 3-48 months follow up period in our study. Tables 1 and 2 summarize 
our experience. Figures 3 to 12 show the patients with tracheobronchial stenosis who 
underwent BBD. 
Respiratory functional improvement can be obtained after BBD, as well as improved 
tracheobronchial diameter. Lee et al. (K. H. Lee et al., 2002) reported significant 
improvements in the mean forced vital capacity (FVC), forced expiratory volume in 1 
second (FEV1), and forced expiratory flow 25%-75% after technically and clinically 
successful balloon dilation in 49 patients. Lee et al. (K. W. Lee et al., 1999) reported that 
improvement of dyspnea occurred immediately in 11 of 15 patients (73%) after balloon  
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Patient Age Sex C.C. Etiology Area Length Severity 
1 42 F DOE Tb Tr 4cm 70% 
2 60 F DOE Tb Tr 3cm 70% 
3 30 M # Tracheostomy Tr 6cm 70% 
4 33 F Cough, Sputum Tb Lt-MB 2cm Pinhole 
5 19 M DOE Tb 
Lt-MB 2cm Pinhole 
Lt-UB 0. 5cm Pinhole 
6 38 M DOE Bronchoplasty Rt-MB 1cm Pinhole 
7 48 F DOE Tb 
Tr 6cm 80% 
Rt-MB 2cm pinhole 
8 30 M Cough, Stridor Tb 
Lt-MB 5cm 70% 
Lt-LB 1cm Pinhole 
C.C=Chief complaint, DOE=Dyspnea on excertion, #=Difficulty in removing tracheostomy tube, 
Tb=Tuberculosis, Tr=Trachea, Lt-MB left main bronchus, Lt-UB=left upper bronchus, Rt-MB=right 
main bronchus, Lt-LB=left lower bronchus 
Table 1. Patients underwent bronchoscopic balloon dilation 
 
Patient Anes. 
Balloon Catheter Pressure 
Complications Patency 
(d×l, mm) (atm) 
1 G 18×55 3 None 3 mos good 
2 G 12~15×55 3 Laceration 4 mos good 
3 G 18 × 80 2~4 Laceration Fair 
4 L 10 × 40 4 None 3 yrs good 
5 
L 10×40, 12×55 3~4 None 3 yrs good 
L 10×20 3~4 None 3 yrs good 
6 L 10×20 6 None 3 yrs good 
7 
G 8~18×80 3~8 Laceration 4 yrs good 
G 8~12×55 3~8 Laceration 4 yrs good 
8 
G 6~10×55 3~10 Laceration 2 yrs good 
G 4~6×20 7~12 None 2 yrs good 
Anes.=anesthesia, G=general anesthesia, L=local anesthesia, d=diameter, l=length, atm=atmosphere, 
BBDs=balloon dilations, mos=months, yrs=years 
Table 2. Details and results of bronchoscopic balloon dilation 
dilation and an increase of FEV1 or FVC of more than 15% after BBD was obtained in five of 
13 patients after 1 or 2 days and that eight of the 13 patients (62%) showed improvement of 
FEV1 or FVC after 1 year. Hautmann et al. (Hautmann et al., 2001) reported that lung 
function analysis demonstrated a small but significant increase in FEV1, peak expiratory 
flow rate (PEFR), FEV1/FVC, and PaO2 within 72 hours after BBD in 42 patients with 
malignant tracheobronchial disease. In our study, the improvements in symptoms such as 
dyspnea, cough, and stridor following dilation were dramatic in most patients. Patients’ 
respiratory status was evaluated before and after BBD by means of pulmonary function test 
and Hugh-Jones classification (Table 3). All patients showed improvements of FEV1, peak 
expiratory flow (PEF) and Hugh-Jones classification (Fig. 13). Thus, BBD is useful not only 
for increasing the tracheobronchial diameter of the stenotic segment but also for improving 
respiratory function and symptoms. 
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        (a)                (b) 
Fig. 3. Tuberculous bronchial stenosis of a 19-year-old man (patient 5). a) Pre-balloon 
dilation bronchoscopic view shows severe stenosis at the left main bronchus. The orifice is 
almost obstructed. b) Bronchoscopy three years after balloon dilation shows an almost 
normal airway. His symptoms immediately improved and he has done well. 
 
 
  
 
        (a)                (b) 
Fig. 4. Post-bronchoplastic stenosis of a 38-year-old man (patient 6). a) Pre-balloon dilation 
bronchoscopic view shows pinhole size opening of the right main bronchus. b) At follow up 
bronchoscopy 3 years after BBD an almost normal lumen of the right main bronchus is 
maintained. He is doing well without evident respiratory symptoms. 
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Fig. 5. Tuberculous tracheal and right main bronchial stenosis of a 48-year-old female 
(patient 7). She had progressive severe dyspnea at rest with continuous coughing and 
stridor. Three-dimensional reconstruction CT shows 60mm segment of 8mm diameter 
severe narrowing from upper trachea to right main bronchus. 
 
   
 
            (a)    (b)          (c) 
Fig. 6. a) Pre-balloon dilation bronchoscopic view of patient 7 shows severe long segmental 
stenosis at the trachea. b) Immediately after balloon dilation, a deep laceration is observed 
from the trachea to the right main bronchus at the membrane portion, but the patient is 
stable and asymptomatic. c) Two months later, the laceration is spontaneously healed and 
the airway is markedly wider than before dilation. Following the balloon dilation the patient 
is less dyspnetic at rest and can perform housework without becoming short of breath. 
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             (a)     (b)           (c) 
Fig. 7. a) Pre-balloon dilation bronchoscopic view of patient 7 shows severe stenosis of the 
right main bronchus. b) Immediately after balloon dilation, a deep laceration is observed at 
the right main bronchus. c) Bronchoscopic findings two months after dilation demonstrate 
that the laceration is spontaneously healed and the airway is significantly improved. 
 
 
 
 
     (a)      (b) 
Fig. 8. a) Fluoroscopic image of patient 7 obtained at the beginning of balloon inflation 
clearly demonstrates a waist (arrow) on the wall of the balloon at the level of the severe part 
of the stenosis. b) Fluoroscopic image obtained at the end of the dilation no longer shows a 
waist. 
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        (a)               (b) 
 
  
 
         (c)                (d) 
Fig. 9. Chest CT of patient 7 shows severe stenosis of the trachea (a) and the right main 
bronchus (b) before BBD. However, BBD brings a significant increase in the diameter of the 
trachea (c) and the right main bronchus (d).  
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Fig. 10. Tuberculous stenosis of the left main bronchus and left lower bronchus of a 30-year-
old male (patient 8). He developed continuous stridor and cough. Three-dimensional 
reconstruction CT shows irregular luminal narrowing from the left main bronchus to the left 
lower bronchus (arrow). 
  
         (a)                (b) 
  
         (c)                 (d) 
Fig. 11. a-b) Pre-balloon dilation bronchoscopic view of patient 8 shows severe stenosis at 
the left main bronchus (a) and the left lower bronchus (arrow in (b)). c-d) Bronchoscopic 
view shows improvement of the stenosis at the left main bronchus (c) and the left lower 
bronchus (d) after balloon dilation. 
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          (a)               (b) 
 
 
 
 
          (c)            (d) 
 
Fig. 12. a) Chest CT of patient 8 shows the stenosis of the left main bronchus (arrow). b) 
Chest CT shows the atelectasis of the left lower lobe caused by tuberculous bronchial 
stenosis (arrow heads). c) After balloon dilation. Chest CT shows increase of the diameter of 
the left main bronchus (arrow). d) After balloon dilation, the atelectasis is obliterated and 
the left lower lobe is expanded (arrow heads). He has been without symptoms and chest 
film evidence of atelectasis for 2 years. 
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    (a)     (b)            (c) 
Fig. 13. All patients who underwent pulmonary function testing showed improvement of 
forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF) and Hugh-Jones 
classification. 
 
I 
The patient's breathing is as good as that of others of the same sex, age, and build while at work, on 
walking, or on climbing hills or stairs 
II 
The patient is able to walk with healthy persons of the same sex, age, and build on the level but is 
unable to keep up on hills or stairs 
III 
The patient is unable to keep up with healthy persons on the level but is able to walk a mile or more 
at a slower speed 
IV The patient is unable to walk more than about 100 yards on the level without a rest 
V 
The patient is breathless on talking or undressing or is unable to leave the house because of 
breathlessness 
Table 3. Hugh-Jones classification  
6. Conclusion 
Bronchoscopic balloon dilation is a very useful therapy for benign tracheobronchial stenosis. 
The advantages of this procedure in comparison with other procedures are that it is 
minimally invasive, safe, and rapid. It can be performed under either local or general 
anesthesia. Balloon dilation can be performed safely and effectively because the balloon 
placement and inflation-deflation can be monitored via both fluoroscopy and bronchoscopy. 
A guidewire permits easy exchange of the balloon catheter. A relatively common 
complication is transmural laceration, but lacerations should be regarded as an expected 
result of sufficient balloon dilation and not as a major complication. No deaths have been 
attributed directly to balloon dilation alone. Only fibrous stenosis responds to balloon 
dilation alone; bronchial stenosis with coexisting tracheobronchomalacia usually requires 
combination therapy with another therapeutic modality such as stent placement to maintain 
bronchial patency. The procedure often needs to be repeated to achieve a satisfactory result. 
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